Iron Triangle Partners LP - Q2 2022 holdings

$771 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$150,900,000400,000
+100.0%
19.57%
HUM NewHUMANA INC$46,807,000100,000
+100.0%
6.07%
RGEN NewREPLIGEN CORP$40,600,000250,000
+100.0%
5.26%
BSX NewBOSTON SCIENTIFIC CORP$37,270,0001,000,000
+100.0%
4.83%
NBIX NewNEUROCRINE BIOSCIENCES INC$34,118,000350,000
+100.0%
4.42%
BIO NewBIO RAD LABS INCcl a$28,688,00057,955
+100.0%
3.72%
LEGN NewLEGEND BIOTECH CORPsponsored ads$27,243,000495,329
+100.0%
3.53%
CI NewCIGNA CORP NEW$21,082,00080,000
+100.0%
2.73%
INSP NewINSPIRE MED SYS INC$20,813,000113,938
+100.0%
2.70%
ESTA NewESTABLISHMENT LABS HLDGS INC$17,674,000325,008
+100.0%
2.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings